Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.

Fluconazole (UK 49,858), a new orally administered bis-triazole, was compared with ketoconazole for activity in synthetic broth dilution susceptibility tests against Candida albicans and also in treatment of experimental systemic candidal infections in rats. In vitro studies indicated that fluconazo...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Rogers, T E, Galgiani, J N
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1986
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180572/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3022641/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.3.418
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!